Being obese raises the risk of developing several immune-related diseases, including types of arthritis and type 1 diabetes, but not all such conditions.
Researchers looked at health records from many adults to compare people with obesity (BMI ≥30) to those without obesity. They found that obesity was linked to higher chances of getting certain immune-mediated inflammatory diseases, especially psoriatic arthritis, type 1 diabetes, and rheumatoid arthritis; for example, people with obesity had about a 74% higher risk of psoriatic arthritis. For two conditions, Sjögren's syndrome and systemic sclerosis, obesity was linked to a slightly lower risk. The study also showed that for some diseases (like rheumatoid arthritis and psoriasis), the more excess weight people had, the higher their risk — this is called a dose-response pattern, like turning up a dimmer switch. The results stayed similar when the researchers tried different ways of checking the data, which makes the findings more reliable.
People with MS and their caregivers should know this because obesity affects the immune system and could change how other immune diseases start or act, which might affect overall health and treatment choices. If you have MS, extra weight might increase the chance of developing another immune-related problem, similar to how poor road conditions can make a car more likely to have another breakdown. Caregivers and family members can help by supporting healthy eating, activity, and weight management — small changes can add up like regular maintenance on a car. Healthcare providers who treat people with MS may consider weight as one part of a person’s overall risk profile and may discuss weight goals or referrals to dietitians or physical therapy. People with MS who are thinking about symptom management, medications, or surgery should mention weight concerns to their care team because it can influence outcomes and risk of other conditions.
This study used electronic health records, which can miss details like exact diet, exercise, or how long someone has been obese — so we can’t say obesity causes these diseases for sure, only that they tend to happen more often together. The research looked at many adults but did not include people under 18 or pregnancy-related situations, so results may not apply to those groups. Also, while the study adjusted for many factors, some things that affect disease risk (like smoking or family history) might not have been perfectly recorded, so take the findings as helpful but not definitive for individual cases.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/1/2026
Discover how the CEAM tool aids in understanding DNA changes in brain cells, offering hope for bette
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read More3/1/2026
Learn about the risks of enterovirus encephalitis for MS patients on ocrelizumab and how early recog
Read More3/1/2026
Learn how TREM2 helps brain immune cells switch to a repair mode, reduce inflammation, and may suppo
Read More3/1/2026
Discover how new research could help women with MS produce more IL-10, an important substance for co
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Scientific reports often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.